Trial intelligence / Profile preview

Preoperative aspirin for prevention of thromboembolism in orthopedic surgery

ISRCTN59381053Phase 2Completed

Sponsor
Sultan Qaboos University Hospital
Start
Mar 2026
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of aspirin in venous thromboembolism (VTE), sponsored by Sultan Qaboos University Hospital. Primary endpoint: Incidence of venous thromboembolism. Started Mar 2026; status: completed.

02

Drugs

aspirin
03

Conditions

venous thromboembolism (VTE)

Beyond the preview

Go deeper on ISRCTN59381053.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN59381053.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call